Context Therapeutics Inc. (CNTX)
Nasdaq: CNTX · Pharmaceutical Preparations · Philadelphia, PA · filing with the SEC since 2021
Who runs Context Therapeutics Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Lehr Martin A.
Chief Executive Officer. First filing Oct 2021, latest Feb 23, 2026, 12 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
15 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Lehr Martin A. | Chief Executive Officer | Oct 2021 | Feb 23, 2026 | none |
| Minai-Azary Jennifer Lynn | Chief Financial Officer | Nov 2021 | Feb 23, 2026 | none |
| Chagin Karen Deborah | Chief Medical Officer | Jun 2025 | Feb 23, 2026 | none |
| Levit Alex C. | Chief Legal Officer, Corp. Sec | Oct 2021 | Feb 23, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kantoff Philip W. | director | Oct 2021 | Jun 26, 2026 | none |
| Pasternak Andy | director | Jan 2025 | Jun 26, 2026 | none |
| Smith Karen L. | director | Sep 2024 | Jun 26, 2026 | none |
| Stacey Jennifer Evans | director | Oct 2021 | Jun 26, 2026 | none |
| Walker Luke Nathaniel | director | Sep 2024 | Jun 26, 2026 | none |
| West Linda | director | Oct 2021 | Jun 26, 2026 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.